1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Differences between drug utilisation estimates based on pharmacy sales and on purchases by the resident population.
(
- Contribution to journal › Article
- 2002
-
Mark
Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.
(
- Contribution to journal › Scientific review
-
Mark
Bättre läkemedelsbehandling kan gynna folkhälsan en studie av möjliga läkemedelsinteraktioner i apoteksexpedieringar
(
- Contribution to journal › Article
-
Mark
Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study
(
- Contribution to journal › Article
- 2001
-
Mark
Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study
(
- Contribution to journal › Article
- 2000
-
Mark
Use of calcium channel blockers and beta blockers as antihypertensives in relation to mortality in type 2 diabetes patients: a population-based observational study.
(
- Contribution to journal › Article
- 1999
-
Mark
Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities
(
- Contribution to journal › Article
-
Mark
Utilization of cardiovascular drugs (blood pressure lowering drugs, lipid lowering drugs and nitrates) and mortality from ischaemic heart disease and stroke. An ecological analysis based on Sweden's municipalities
(
- Contribution to journal › Article
- 1998
-
Mark
Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study
(
- Contribution to journal › Article
- 1997
-
Mark
The association between serum sialic acid and asymptomatic carotid atherosclerosis is not related to antibodies to herpes type viruses or Chlamydia pneumoniae. The Atherosclerosis Risk in Communities (ARIC) Study Investigators
(
- Contribution to journal › Article